References
inflammation
INFLAMMATION, INTERACTION
CONSORT Diagram indicating the selection of children into growth biomarker sub-study. Detailed CONSORT including an explanation of exclusions is published elsewhere [Effect-modification by baseline IGF1 of the response in length-for-age z-score (LAZ) at 18 weeks to zinc-alone or zinc-containing MNP in rural Laotian children. Bars with different letters are significantly different (Effect-modification by baseline IGFBP3 of the response in weight for-age z-score (WAZ) after 36 weeks to zinc-alone or zinc-containing MNP in rural Laotian children. Bars with different letters are significantly different (Association between baseline length-for-age z-scores and IGF1 concentrations.Distributions of IGF1, IGFBP3, and molar IGF1:IGFBP3 ratio at baseline and 36 weeks later in rural Laotian children.Demographic data, nutritional status, and growth biomarker concentrations at baseline in intervention groups.* Results are shown as mean ± SD or N (%); For growth biomarkers, results are shown as geometric mean (95% confidence interval). Plasma zinc concentration < 65 mg/dL and adjusted for inflammation as recommended by the BRINDA project [Effects of 32—40 weeks of supplementation with daily preventive zinc supplements, daily MNP on Insulin-like Growth Factor 1 (IGF1) and Insulin-like Growth Factor 1 Binding Protein (IGFBP3) among rural Laotian children.* Values adjusted for age, sex, district baseline values of IGF1, IGFBP3, length-for-age z-score, weight-for age z-score, and weight –for-length z-score.Interaction between baseline IGF1 or IGFBP3 and zinc supplementation in predicting physical growth at 18 weeks and 36 weeks.